Skip to main content
Lauren Pinter-Brown, MD, Oncology, Orange, CA, UCI Health

LaurenCarolePinter-BrownMD

Oncology Orange, CA

Hematologic Oncology

Professor, Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC Irvine

Dr. Pinter-Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pinter-Brown's full profile

Already have an account?

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1984 - 1986
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1983 - 1984
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase 2 Study of Everolimus for Relapsed or Refractory Classical Hodgkin Lymphoma  
    Patrick B. Johnston, Radhakrishnan Ramchandren, Lauren C. Pinter-Brown, BioMed Central

Abstracts/Posters

  • Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
    Lauren C. Pinter-Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • SOHO 2021: An Update of Lymphoma Treatments in Five Parts
    SOHO 2021: An Update of Lymphoma Treatments in Five PartsSeptember 20th, 2021
  • New Publication Offers Insight into POTELIGEO® (Mogamulizumab-Kpkc) Treatment Response in Cutaneous T-cell Lymphoma Patients with Varying Levels of Blood Involvement
    New Publication Offers Insight into POTELIGEO® (Mogamulizumab-Kpkc) Treatment Response in Cutaneous T-cell Lymphoma Patients with Varying Levels of Blood InvolvementJuly 22nd, 2021
  • Nephrotic Syndrome Reported with Everolimus, Voriconazole
    Nephrotic Syndrome Reported with Everolimus, VoriconazoleJuly 8th, 2017

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations